The net profit of Danish pharmaceutical company LEO Pharma peaked in 2014 at 1.54 billion Danish kroner. The following years, the company made profits, but fluctuating. In 2021 and 2022, net losses amounted to record highs of around 4.9 billion and 4.1 billion Danish kroner, respectively. Leo Pharma is a Danish pharmaceutical company founded 1908. The company's key products are dermatological pharmaceuticals.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
LEO Pharma, & Nasdaq Nordic. (February 26, 2025). Net profit of LEO Pharma from 2009 to 2024 (in million DKK) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 21, 2026, from /statistics/954250/net-profit-of-leo-pharma/
LEO Pharma, und Nasdaq Nordic. "Net profit of LEO Pharma from 2009 to 2024 (in million DKK) ." Chart. February 26, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 21, 2026. /statistics/954250/net-profit-of-leo-pharma/
LEO Pharma, Nasdaq Nordic. (2025). Net profit of LEO Pharma from 2009 to 2024 (in million DKK) . ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 21, 2026. /statistics/954250/net-profit-of-leo-pharma/
LEO Pharma, and Nasdaq Nordic. "Net Profit of Leo Pharma from 2009 to 2024 (in Million Dkk) ." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 26 Feb 2025, /statistics/954250/net-profit-of-leo-pharma/
LEO Pharma & Nasdaq Nordic, Net profit of LEO Pharma from 2009 to 2024 (in million DKK) ÌÇÐÄÆƽâ°æ, /statistics/954250/net-profit-of-leo-pharma/ (last visited July 21, 2026)
Net profit of LEO Pharma from 2009 to 2024 (in million DKK) [Graph], LEO Pharma, & Nasdaq Nordic, February 26, 2025. [Online]. Available: /statistics/954250/net-profit-of-leo-pharma/
